Volume: 3, Issue: 3
ABSTRACT
Phytopharmaceuticals, derived from plant sources, are gaining global popularity as consumers shift toward natural remedies. India, with its rich biodiversity and traditions in Ayurveda, Unani, and Siddha, plays a key role in this market, which was valued at USD 83 billion in 2019 and growing at 6.5% CAGR. Government initiatives like the Ministry of AYUSH and Phytopharmaceutical Drug Guidelines (2015) promote quality and standardization. Despite challenges in regulation and competition with synthetic drugs, India's strong research potential and public-private collaborations position it well for growth in the global phytopharmaceutical industry.
Phytopharmaceuticals, Ayurveda, Natural remedies, Standardization, Biodiversity